Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA's Expectations And Firms’ Responsibilities Clarified In Voluntary Recalls Final Guidance

Mar 04 2022

• By Malcolm Spicer

• Source: Alamy

Related Content

'Mock' Recalls Suggested, But US FDA Isn't Joking About Recalling Products

Apr 24 2019

Las Vegas Kratom Marketer Rolls Dice On FDA's Mandatory Recall Authority

Apr 03 2018

Recalls With Potential For Serious Health Risks Will Identify Points Of Sale

Oct 08 2018

Additional Topics

International United States US States FDA Guidance Documents Recalls Advertising, Marketing & Sales Commercial Compliance Consumer Coronavirus COVID-19 Dietary Supplements Cosmetics Drug Safety Ingredients Manufacturing OTC Drugs OTC Devices Policy Regulation

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window